Arkolith/Insider Trading/TPST/Form 4

Angel Matthew

CEO and President, Director, 10% OwnerTempest Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Jun 23, 2026
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Buy(P)231K$2.16$500K231K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Buy(P)231K——231K
Mar 24, 2026Buy(P)231K——231K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-279703) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Tempest Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp